Advancing regenerative cell therapies to help protect and restore peripheral nerve function in inherited and acquired neuropathies, including Charcot-Marie-Tooth disease type 1 and diabetic neuropathy.

Developing regenerative cell therapies that target the underlying joint and cartilage damage in degenerative musculoskeletal conditions such as osteoarthritis.

Targeting validated disease-modifying pathways in IPF, systemic sclerosis, and related conditions with significant unmet medical need.